价格

AML-4

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE
- EP 4081215 A1
  申请人: OHIO STATE INNOVATION FOUNDATION优先权: 2019
  CN
  EP
  US
  WO
  5 件公开
- EP 4438042 A3
  申请人: OHIO STATE INNOVATION FOUNDATION优先权: 2018
  CN
  EP
  US
  4 件公开
- WO 2025227007 A1
  申请人: OHIO STATE INNOVATION FOUNDATION优先权: 2024
  WO
Combination therapy for MDS
US 9168257 B2申请人: CHILDRENS HOSP MEDICAL CENTER优先权: 2014
US
4 件公开
DOSAGE REGIMEN FOR SAPACITABINE AND DECITABINE IN COMBINATION FOR TREATING ACUTE MYELOID LEUKEMIA
EP 3560501 A1申请人: CYCLACEL LTD优先权: 2011
EP
US
3 件公开
COMPOSITIONS FOR USE FOR THE INHIBITION OF DIHYDROOROTATE DEHYDROGENASE
EP 4081512 A1申请人: OHIO STATE INNOVATION FOUNDATION优先权: 2019
EP
US
3 件公开
Therapeutic agents for the treatment of lymphoid malignancies
US 8318812 B2申请人: BYRD JOHN C优先权: 2007
US
3 件公开
Method of treating acute myeloid leukemia and/or acute lymphoblastic leukemia using thienotriazolodiazepine compounds
US 9956228 B2申请人: ONCOETHIX GMBH优先权: 2014
CN
US
2 件公开
EFFICACY OF ANTI-HLA-DR ANTIBODY DRUG CONJUGATE IMMU-140 (hL243-CL2A-SN-38) IN HLA-DR POSITIVE CANCERS
WO 2018031408 A1申请人: IMMUNOMEDICS INC优先权: 2016
CN
WO
2 件公开
METHODS OF TREATMENT
US 20260158048 A1申请人: RIGEL PHARMACEUTICALS INC优先权: 2024
US
WO
2 件公开
COMBINATION THERAPY OF 4-(CYCLOPROPYLAMINO)-2-(4-(4-(ETHYLSULFONYL)PIPERAZIN-1-YL)PHENYLAMINO)PYRIMIDINE-5-CARBOXAMIDE AND FLUDARABINE
US 2013237493 A1申请人: SINHA UMA优先权: 2011
US
2 件公开
Efficacy of anti-HLA-DR antiboddy drug conjugate IMMU-140 (hL243-CL2A-SN-38) in HLA-DR positive cancers
US 10206918 B2申请人: IMMUNOMEDICS INC优先权: 2017
US
2 件公开

药物

AML-4

专利

METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE